Medical breakthroughs often make headlines, but turning a scientific discovery into a medicine is a journey that can take years, and most never make it. On Industry Insight, Lynlee Foo sits down with Dr Alan Russell, Vice President of Research, global biotechnology company Amgen, to explore how the business of biotech has evolved. From the rise of startups and AI-driven drug discovery to the economics of developing new medicines and Singapore's growing biotech ecosystem, they discuss what it really takes to bring life-changing treatments to patients.See omnystudio.com/listener for privacy information.

Medical breakthroughs often make headlines, but turning a scientific discovery into a medicine is a journey that can take years, and most never make it. On Industry Insight, Lynlee Foo sits down with Dr Alan Russell, Vice President of Research, global biotechnology company Amgen, to explore how the business of biotech has evolved. From the rise of startups and AI-driven drug discovery to the economics of developing new medicines and Singapore's growing biotech ecosystem, they discuss what it really takes to bring life-changing treatments to patients.See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

Industry Insight: How the business of biotech is changing